With all these results, we computed a Network Analysis, not restricted to significant variables, to visualize the potential interactions between PD-L1+ leukocyte populations and plasma cytokines in NSCLC patients classified according to their response to anti-PD-(L)1 treatment (Figure 5A). Here, CD274 is linked to non-small cell lung carcinoma.